What is the first noninvasive transdermal system approved by the U.S. Food and Drug Administration to assess kidney function without blood draws or urine samples?
The MediBeacon® Transdermal GFR (TGFR) System. In January 2025, the FDA approved this first-of-its-kind medical device that uses a skin-attached sensor and a fluorescent tracer agent to noninvasively measure a patient’s glomerular filtration rate (GFR), enabling point-of-care kidney function assessment without traditional blood or urine testing. Source: www.medibeacon.com
The Medical Design Briefs trivia questions first appear in the Medical Design Briefs e-Source newsletter. If you would like to be among the first to see the latest question, click the subscribe button below.
Read more from the trivia archives here.
